Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild-Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir
使用莫努匹韦、尼马替韦/利托那韦或瑞德西韦治疗轻中度 COVID-19 高危患者的临床结果和 7 天病毒学清除率
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-00994-3
Bai, Francesca; Beringheli, Tomaso; Vitaletti, Virginia; Santoro, Andrea; Molà, Francesco; Copes, Alessandro; Gemignani, Nicole; Pettenuzzo, Sofia; Castoldi, Roberto; Varisco, Benedetta; Nardo, Riccardo; Lundgren, Lorenzo Brando; Ligresti, Riccardo; Sala, Matteo; Albertini, Lorenzo; Augello, Matteo; Biasioli, Lorenzo; Bono, Valeria; Rovito, Roberta; Bini, Teresa; Passarella, Sabrina; Orfeo, Nicola Vincenzo; Monforte, Antonella d'Arminio; Marchetti, Giulia
